TD Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$386K Buy
3,206
+46
+1% +$5.31K 0.03% 90
2025
Q4
$333K Buy
3,160
+338
+12% +$31.7K 0.03% 98
2025
Q3
$237K Buy
2,822
+14
+0.5% +$1.15K 0.02% 117
2025
Q2
$222K Buy
2,808
+442
+19% +$35.1K 0.02% 116
2025
Q1
$212K Buy
2,366
+160
+7% +$14.9K 0.02% 106
2024
Q4
$219K Buy
2,206
+48
+2% +$4.95K 0.02% 102
2024
Q3
$245K Buy
2,158
+5
+0.2% +$594 0.02% 96
2024
Q2
$267K Buy
2,153
+5
+0.2% +$644 0.03% 92
2024
Q1
$283K Buy
2,148
+5
+0.2% +$616 0.03% 90
2023
Q4
$234K Sell
2,143
-641
-23% -$66.5K 0.03% 92
2023
Q3
$287K Buy
2,784
+9
+0.3% +$970 0.04% 82
2023
Q2
$320K Buy
2,775
+10
+0.4% +$1.14K 0.04% 79
2023
Q1
$294K Buy
2,765
+9
+0.3% +$972 0.04% 75
2022
Q4
$306K Buy
2,756
+12
+0.4% +$1.23K 0.04% 70
2022
Q3
$236K Sell
2,744
-40
-1% -$3.57K 0.03% 78
2022
Q2
$254K Buy
2,784
+97
+4% +$8.6K 0.03% 74
2022
Q1
$220K Sell
2,687
-103
-4% -$8.12K 0.03% 86
2021
Q4
$214K Buy
2,790
+4
+0.1% +$319 0.02% 87
2021
Q3
$209K Buy
2,786
+5
+0.2% +$380 0.03% 81
2021
Q2
$216K Sell
2,781
-128
-4% -$9.52K 0.03% 75
2021
Q1
$214K Buy
2,909
+428
+17% +$31.6K 0.03% 68
2020
Q4
$194K Buy
2,481
+315
+15% +$24.1K 0.03% 65
2020
Q3
$171K Hold
2,166
0.03% 58
2020
Q2
$160K Hold
2,166
0.03% 56
2020
Q1
$159K Hold
2,166
0.03% 57
2019
Q4
$188K Hold
2,166
0.03% 61
2019
Q3
$174K Hold
2,166
0.03% 59
2019
Q2
$173K Hold
2,166
0.04% 50
2019
Q1
$172K Buy
2,166
+10
+0.5% +$748 0.04% 51
2018
Q4
$157K Hold
2,156
0.04% 50
2018
Q3
$146K Hold
2,156
0.04% 50
2018
Q2
$125K Hold
2,156
0.03% 49
2018
Q1
$112K Hold
2,156
0.03% 51
2017
Q4
$116K Hold
2,156
0.03% 55
2017
Q3
$132K Hold
2,156
0.04% 49
2017
Q2
$132K Hold
2,156
0.04% 50
2017
Q1
$131K Hold
2,156
0.04% 51
2016
Q4
$121K Hold
2,156
0.04% 51
2016
Q3
$128K Hold
2,156
0.04% 51
2016
Q2
$119K Hold
2,156
0.04% 55
2016
Q1
$109K Hold
2,156
0.04% 55
2015
Q4
$109K Hold
2,156
0.03% 54
2015
Q3
$102K Hold
2,156
0.03% 61
2015
Q2
$117K Hold
2,156
0.03% 65
2015
Q1
$118K Buy
2,156
+17
+0.8% +$963 0.03% 67
2014
Q4
$116K Buy
2,139
+16
+0.8% +$891 0.03% 69
2014
Q3
$120K Buy
2,123
+15
+0.7% +$842 0.03% 67
2014
Q2
$116K Sell
2,108
-717
-25% -$39.1K 0.03% 61
2014
Q1
$153K Buy
2,825
+18
+0.6% +$932 0.04% 53
2013
Q4
$134K Buy
2,807
+752
+37% +$34.4K 0.03% 57
2013
Q3
$93K Buy
2,055
+20
+1% +$913 0.02% 103
2013
Q2
$90K Buy
+2,035
New +$90.9K 0.02% 96

Other funds holding MRK

TD Capital Management's MRK Position: Q1 2026 in Review

TD Capital Management increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $5.31K and bringing the position to 3,206 shares worth $386K. The position accounts for 0.03% of the portfolio, ranked #90.

TD Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • TD Capital Management held 3,206 shares of Merck worth $386K as of Q1 2026.
  • TD Capital Management bought 46 Merck shares in Q1 2026, an estimated $5.31K.
  • Merck made up 0.03% of TD Capital Management's portfolio in Q1 2026, its #90 holding.
  • TD Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.